Net Sales by Destination, Business and Product type

Net Sales by Destination
Net Sales by Business
Net Sales by Product Type

Net Sales by Destination

Japan11.7%Americas27.9%EMEA31.6%China17.9%Asia-Pacific10.9%

(JPY million)

	2022/3	2023/3	2024/3	2025/3	2026/3
Japan	55,618	59,832	62,184	67,786	58,603
Americas	83,655	105,905	118,782	131,148	139,254
EMEA	94,352	105,200	125,349	140,398	158,034
China	93,373	96,902	109,952	117,970	89,465
Asia-Pacific	36,780	42,661	45,241	51,339	54,649
Total	363,780	410,502	461,510	508,643	500,006

※EMEA: Europe, Middle East, and Africa

Net Sales by Business

Hematology59.9%FCM0.9%Urinalysis8.8%Hemostasis14.5%Immunochemistry4.5%Clinical Chemistry0.6%Life Science5.0%Others5.2%Diagnostics Business99.3%Medical Robotics Business0.7%

(JPY million)

		2022/3	2023/3	2024/3	2025/3	2026/3
Diagnostics Business	Hematology	210,367	241,325	274,915	303,202	299,407
	FCM	2,074	2,262	3,318	3,638	4,690
	Urinalysis	29,978	34,053	39,031	40,838	44,070
	Hemostasis	62,087	66,900	72,934	82,346	72,409
	Immunochemistry	20,414	23,575	23,646	25,871	22,319
	Clinical Chemistry	2,958	3,426	3,378	3,633	2,917
	Life Science	17,980	19,937	20,508	21,324	24,960
	Others	16,624	16,686	20,030	22,417	25,925
Medical Robotics Business		1,294	2,333	3,745	5,371	3,304
Total		363,780	410,502	461,510	508,643	500,006

Net Sales by Product Type

Instruments20.6%Reagents61.6%Service13.9%Others3.9%

(JPY million)

	2022/3	2023/3	2024/3	2025/3	2026/3
Instruments	86,795	91,796	100,959	104,259	103,232
Reagents	216,167	247,535	280,843	313,818	307,923
Service	46,579	54,350	61,446	68,414	69,275
Others	14,238	16,819	18,261	22,150	19,575
Total	363,780	410,502	461,510	508,643	500,006